Latest News and Updates

ZeNix trial shows lower dose of linezolid can be used for treating highly drug resistant tuberculosis

Results from the ZeNix trial show that the BPaL combination of drugs remains effective against highly drug resistant tuberculosis (TB) with reduced dosage or duration of the linezolid part of the regimen.

21 Jul

ODYSSEY trial finds dolutegravir-based HIV treatment is better for babies

The anti-HIV drug dolutegravir, given in combination with other anti-HIV drugs, improves outcomes for babies and young children living with HIV, compared to standard anti-HIV treatment combinations.

19 Jul

UNITE4TB partnership launches

Launch of UNITE4TB partnership marks a new era in Tuberculosis treatment development

15 Jul

New results confirm the benefit of arthritis drugs in hospitalised patients with COVID-19

Findings published today in the Journal of the American Medical Association (JAMA), have prompted new World Health Organization (WHO) recommendations to use the drugs, tocilizumab or sarilumab, along with corticosteroids…

07 Jul

Our Research Themes


Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types


Major international clinical trials answering questions of global public health significance


Development of methods with direct impact on the design, conduct and analysis of studies

Other Research & Policy

This section will capture projects outside the current QQR themes